Journal
ARCHIVES OF PHARMACAL RESEARCH
Volume 39, Issue 2, Pages 249-258Publisher
PHARMACEUTICAL SOC KOREA
DOI: 10.1007/s12272-015-0671-y
Keywords
Phytoestrogens; Cryptotanshinone; Wogonin; Estrogen receptors; Nitric oxide synthase; Cardiovascular disease
Categories
Funding
- National Natural Science Foundation of China [81173592]
- Program for New Century Excellent Talents in University of Ministry of Education of China [NCET-13-0935]
- Program of International S&T Cooperation Project of China [2015DFA30430]
- Major drug discovery National Science and Technology Major Project of the Ministry of Science and Technology of China [2012ZX09101212]
- Program for Changjiang Scholars and Innovative Research Team in University, PCSIRT [IRT1276]
Ask authors/readers for more resources
Phytoestrogens were widely used as natural alternatives to estrogen for treating cardiovascular diseases. They have been reported to have cardioprotective and anti-inflammatory response, but the mechanisms remain unclear. In this study, we found cryptotanshinone and wogonin exhibited phytoestrogenic property in an estrogen-responsive reporter assay. In EA.hy926 cells, treatment of cryptotanshinone and wogonin led to significant increase in NO production levels, which were inhibited by co-incubation of estrogen receptor (ER)alpha antagonist methyl-piperidino-pyrazole (MPP). The expression of endothelial NO synthase (eNOS) and ER alpha were up-regulated with the same treatment, indicating they stimulate NO and eNOS expression via ER alpha-dependent pathway in endothelial cells. While in lipopolysaccharide activated vascular smooth muscle cell line A7r5, cryptotanshinone and wogonin exerted anti-inflammatory effects by inhibiting NO and inducible NO synthase expression via ER beta-dependent pathway. The reduction of NO synthesis was not affected by MPP, and was abrogated by ER beta antagonist R,R-tetrahydrochrysene. Our findings provide the potential molecular mechanism of cryptotanshinone and wogonin as phytoestrogens for their cardioprotective effects, which exerted regulatory effects on NO synthesis through differential regulation of estrogen receptors. It can be employed as a basis for evaluating the beneficial effects of phytoestrogens in the treatment of patients at risk of cardiovascular disease.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available